Pacific Biosciences
PACB
PACB
141 hedge funds and large institutions have $432M invested in Pacific Biosciences in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 27 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less call options, than puts
Call options by funds: $4.08M | Put options by funds: $5.66M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
141
Holding in Top 10
2
Calls
$4.08M
Puts
$5.66M
Top Buyers
| 1 | +$17.7M | |
| 2 | +$12.3M | |
| 3 | +$7.64M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$6.28M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6.19M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$8.07M | |
| 3 | -$7.65M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$5.95M |